Ear Care in Kazakhstan

April 2013 | 19 pages | ID: E428D344E4EEN
Euromonitor International Ltd

Abstracts

Towards the end of the review period, consumers suffering from ear ailments still typically preferred to seek advice from a doctor instead of self-medicating, with doctors often recommending expensive but more effective remedies with fewer side effects. The fact that consumers typically use Rx medication to treat ear care problems hampered the potential growth for OTC ear care.

Euromonitor International's Ear Care in Kazakhstan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Ear Care market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

EAR CARE IN KAZAKHSTAN
Euromonitor International
April 2013

Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
  Table 1 Sales of Ear Care: Value 2007-2012
  Table 2 Sales of Ear Care: % Value Growth 2007-2012
  Table 3 Ear Care Company Shares 2008-2012
  Table 4 Ear Care Brand Shares 2009-2012
  Table 5 Forecast Sales of Ear Care: Value 2012-2017
  Table 6 Forecast Sales of Ear Care: % Value Growth 2012-2017
Executive Summary
Consumer Health Growth Slightly Higher Than the Review Period
Unit Prices Remain S  Table in 2012
International Companies Dominate and Sustain Leadership
Chemists/pharmacies Is Dominant Distribution Channel
Stronger Forecast Value Sales Envisaged
Key Trends and Developments
General Health and Wellness Trend Positively Effects Consumer Health in Kazakhstan
Pharmaceutical Channel Increasingly Concentrated
Rapid Urbanisation Impacts Consumer Health Market
Market Indicators
  Table 7 Consumer Expenditure on Health Goods and Medical Services 2007-2012
  Table 8 Life Expectancy at Birth 2007-2012
Market Data
  Table 9 Sales of Consumer Health by Category: Value 2007-2012
  Table 10 Sales of Consumer Health by Category: % Value Growth 2007-2012
  Table 11 Consumer Health Company Shares 2008-2012
  Table 12 Consumer Health Brand Shares 2009-2012
  Table 13 Sales of Consumer Health by Distribution Format: % Analysis 2007-2012
  Table 14 Sales of Consumer Health by Category and Distribution Format: % Analysis 2012
  Table 15 Forecast Sales of Consumer Health by Category: Value 2012-2017
  Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2012-2017
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Summary 1 OTC Healthcare Switches 2010-2012
Sources
Summary 2 Research Sources